Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis

被引:0
作者
Sally Temraz
Deborah Mukherji
Zein Al Abideen Farhat
Rami Nasr
Maya Charafeddine
Mohammed Shahait
Mohammad Rachad Wehbe
Rami Abou Ghaida
Ibrahim Abu Gheida
Ali Shamseddine
机构
[1] Departments of Hematology-Oncology,Urology, and Radiation Oncology
[2] General Surgery,Radiation Oncology
[3] American University of Beirut Medical Center,undefined
[4] American University of Beirut Medical Center,undefined
来源
BMC Urology | / 14卷
关键词
Urinary bladder neoplasms; Transitional cell carcinoma; Inflammation; Lymphocytes; Monocytes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 180 条
[1]  
Grivennikov SI(2010)Immunity, inflammation, and cancer Cell 140 883-899
[2]  
Greten FR(2008)Cancer-related inflammation Nature 454 436-444
[3]  
Karin M(2000)Non-steroidal anti-inflammatory drugs and bladder cancer prevention Br J Cancer 82 1364-1369
[4]  
Mantovani A(2008)Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma World J Surg 32 1757-1762
[5]  
Allavena P(2009)Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment Cancer Immunol Immunother 58 15-23
[6]  
Sica A(2012)Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma Biomarkers 17 539-544
[7]  
Balkwill F(2012)Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer Biomarkers 17 216-222
[8]  
Castelao JE(2012)Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer J Gynecol Oncol 23 265-273
[9]  
Yuan JM(2014)Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients Cancer Med 3 406-415
[10]  
Gago-Dominguez M(2014)Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder Br J Cancer 111 444-451